Clinical Trials Search

Title Intervention NCT IDsort descending Sponsor Status
S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and... therapeutic conventional surgery, gastrointestinal complications management/prevention, quality-of-life assessment NCT02270450 Southwest Oncology Group Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 International Breast Cancer Study Group Active, not recruiting
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration NCT02314156 Northwestern University Active, not recruiting
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Rilimogene Galvacirepvec, Placebo Administration NCT02326805 National Cancer Institute (NCI) Active, not recruiting
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Magnetic Resonance Imaging, Therapeutic Conventional Surgery, Therapeutic Surgical Procedure, Radiation Therapy, Endocrine Therapy, Quality-of-Life Assessment, Laboratory Biomarker Analysis, Cytology Specimen Collection Procedure NCT02352883 ECOG-ACRIN Cancer Research Group Active, not recruiting
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After... bevacizumab, corticosteroids, placebo NCT02490878 Alliance for Clinical Trials in Oncology Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger... Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine NCT02568566 National Cancer Institute (NCI) Active, not recruiting
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride NCT02581137 National Cancer Institute (NCI) Active, not recruiting

Pages